Yirijian is a provider of digital intelligence solutions for the pharmaceutical industry, a state-owned second-tier wholly-owned subsidiary, focusing on providing intelligent system development and upgrading business for new pharmaceutical retail, and providing artificial intelligence and remote consultation and other related services. Recently, Yirijian received RMB 300 million in strategic financing. The leading investor this time is IDG Global Capital, followed by JD Technology and China Resources Capital, with a post-investment valuation of RMB 3.3 billion. This round of financing will be used for market expansion, data upgrades, product development, user subsidies, and national market layout.
This article is transferred from: https://www.itjuzi.com/investevent/13742348
This site is only for collection, and the copyright belongs to the original author.